Get the app
USHealthcare

Agilent Technologies Inc (A)

US · Healthcare · Diagnostics & Research

$156.35+1.73%
Last close · 2026-09-17

Latest quarter · ended 2026-07-31

Revenue
$1.88B
Revenue YoY
+8.1%
Net profit
$362.0M
Profit YoY
+7.7%
EPS
$1.62
EPS estimate
$1.48
Net margin
19.3%

EPS came in at 1.62 against a street estimate of 1.48 — a beat of 9.5%.

Key statistics

Market cap
$42.37B
P/E
29.0
Forward P/E
21.2
P/B
5.62
Book value
$26.11
EPS (TTM)
$5.18
Dividend yield
0.69%
52-week high
$163.75
52-week low
$108.14
50-day MA
$143.58
200-day MA
$131.54
Beta
1.24

Analyst view

Analysts rate Agilent Technologies Inc a buy (14 buy, 3 hold, 0 sell out of 17) with an average price target of $174.95.

From the latest earnings call · 2026-08-26

CONFIDENT Agilent crushed Q3 with 7.3% core growth, 27.2% operating margin, and $1.56 EPS (ex-refunds), beating guidance. Raised FY26 guidance to 5.8–6% growth and $6.12–$6.15 EPS. Pharma +12%, China +9%, innovation pipeline strong. Q3 FY26 China accelerated to +9% vs. flat expectation on pharma and food strength; reshoring orders in pharma from 5 of top 10 companies in Q3 alone. Americas broad-based. Europe faced tough comps. No analyst Q&A segment recorded in transcript; call transitioned directly from CFO remarks to close without analyst questions. 2026-08-26…

Full summary in the app.

Shareholding

Insiders
0.19%
Institutions
95.47%

Largest institutional holders

FundStake
BlackRock Inc9.19%
Vanguard Capital Management, LLC6.52%
Vanguard Portfolio Management, LLC5.09%
State Street Corp4.53%
Massachusetts Financial Services Company4.48%
T. Rowe Price Investment Management,Inc.3.19%
Geode Capital Management, LLC2.67%
Wellington Management Company LLP2.64%

Recent filings & reports

DocumentDate
Board / officer change · Q4 FY2026
AGILENT TECHNOLOGIES, INC. - 8-K SUMMARY HEADLINE NUMBERS • Report Date: September 2, 2026 (earliest event reported); filed September 8, 2026 • Comp
2026-09-08
Quarterly report · Q3 FY2026
AGILENT TECHNOLOGIES, INC. - QUARTERLY REPORT SUMMARY (Q3 FY2026) HEADLINE NUMBERS • Q3 2026 (3 months ended July 31, 2026): Net revenue $1,878 mill
2026-09-01
Results announced · Q4 FY2026
AGILENT TECHNOLOGIES Q3 FY2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Q3 Revenue: $1.88 billion, up 8.1% reported and 7.3% core year-over-year • GAAP
2026-08-26
Material agreement · Q3 FY2026
AGILENT TECHNOLOGIES, INC. – 8-K SUMMARY HEADLINE NUMBERS • Company closed sale of $600 million in Senior Notes on June 25, 2026 • Notes issued at 9
2026-06-25
Quarterly report · Q2 FY2026
AGILENT TECHNOLOGIES, INC. – Q2 FY2026 10-Q SUMMARY HEADLINE NUMBERS • Q2 2026 Net Revenue: $1,835 million (Q2 2025: $1,668 million) — up 10% year-o
2026-06-01
Results announced · Q3 FY2026
AGILENT TECHNOLOGIES Q2 FY2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 FY2026 revenue: $1.83 billion, up 10.0% reported, up 6.3% core year-over-year
2026-05-27
Quarterly report · Q1 FY2026
AGILENT TECHNOLOGIES, INC. – Q1 FY2026 10-Q SUMMARY HEADLINE NUMBERS • Total net revenue Q1 FY2026: $1,798 million (vs. $1,681 million in Q1 FY2025)
2026-03-03
Proxy statement · Q2 FY2026
AGILENT TECHNOLOGIES, INC. – PROXY STATEMENT SUMMARY EXECUTIVE PAY • CEO total compensation (fiscal 2025): Not explicitly stated in provided documen
2026-02-06

Readable in the app.

Corporate actions

ActionDetailDate
Dividend$0.26 / share
ex-date Jun 30, 2026 · pay Jul 22, 2026
2026-06-30
Dividend$0.26 / share
ex-date Mar 31, 2026 · pay Apr 22, 2026
2026-03-31
Dividend$0.26 / share
ex-date Jan 6, 2026 · pay Jan 28, 2026
2026-01-06
Dividend$0.25 / share
ex-date Sep 30, 2025 · pay Oct 22, 2025
2025-09-30

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Agilent Technologies Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.